Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Shares Outstanding (2020 - 2025)

Sight Sciences has reported Shares Outstanding over the past 6 years, most recently at $53.5 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $53.5 million for Q4 2025, up 5.02% from a year ago — trailing twelve months through Dec 2025 was $53.5 million (up 5.02% YoY), and the annual figure for FY2025 was $53.5 million, up 5.02%.
  • Shares Outstanding for Q4 2025 was $53.5 million at Sight Sciences, up from $52.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding for SGHT hit a ceiling of $53.5 million in Q4 2025 and a floor of $9.5 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $48.7 million (2023), compared with a mean of $45.6 million.
  • Biggest five-year swings in Shares Outstanding: soared 404.4% in 2021 and later increased 1.33% in 2023.
  • Sight Sciences' Shares Outstanding stood at $47.5 million in 2021, then increased by 1.67% to $48.3 million in 2022, then increased by 1.73% to $49.1 million in 2023, then rose by 3.68% to $50.9 million in 2024, then grew by 5.02% to $53.5 million in 2025.
  • The last three reported values for Shares Outstanding were $53.5 million (Q4 2025), $52.5 million (Q3 2025), and $52.0 million (Q2 2025) per Business Quant data.